Seoul National University Bundang Hospital (SNUBH)
| República da Coreia | Turquia | Áustria | |
| Terapia com células estaminais para a doença de Alzheimer | de $28,814 | de $15,000 | de $40,000 |
A Bookimed não adiciona taxas extras aos preços de tratamento de Doença de Alzheimer. As tarifas vêm das listas oficiais de preços das clínicas. O pagamento é feito diretamente na clínica na chegada ao país.
A Bookimed está comprometida com sua segurança. Trabalha apenas com instituições que mantêm altos padrões internacionais no tratamento de Doença de Alzheimer e têm as licenças necessárias para atender pacientes internacionais em todo o mundo.
A Bookimed oferece assistência gratuita de especialistas. Um coordenador médico pessoal apoia antes, durante e após o tratamento, solucionando problemas. Nunca está sozinho em sua jornada de tratamento de Doença de Alzheimer.
O Hospital Severance — o maior hospital multidisciplinar da Coreia do Sul. Foi o primeiro no país a receber a prestigiosa acreditação americana pela qualidade do tratamento — JCI.
A especialização do Severance — oncologia, check-up (exame de saúde), cirurgia da coluna, cirurgia cardíaca e oftalmologia.
As conquistas do hospital incluem a primeira cirurgia cardíaca robótica na Coreia e a primeira implantação na Ásia de um disco espinhal artificial na região cervical.
Anualmente, o Hospital Severance recebe para tratamento mais de 1 000 000 de pacientes internados, dos quais 30 000 são estrangeiros.
O Hospital Gangnam Severance é o maior hospital multidisciplinar de Seul, Coreia do Sul.
Especialização — oncologia, neurocirurgia, neurologia, cardiologia e check-up (exame abrangente).
A clínica foi uma das primeiras em Seul a obter a acreditação americana Joint Commission International. Isso confirma a conformidade com os padrões internacionais de segurança no tratamento e o uso de métodos modernos.
Entre as conquistas do centro médico — o primeiro transplante de pulmão na Coreia do Sul.
Mais de 900 procedimentos realizados em 41 anos – Byung-hee Lee é especializado na doença de Alzheimer com foco em neurologia intervencionista.
The latest Alzheimer drug available in South Korea is Leqembi (lecanemab). The Ministry of Food and Drug Safety (MFDS) approved it in May 2024. It launched for clinical use in November 2024. This monoclonal antibody targets amyloid-beta plaques to slow cognitive decline.
Bookimed Expert Insight: While major centers like Asan Medical Center and Severance Hospital offer standard drug therapies, specialty clinics are emerging with localized delivery methods. RE:YOUTH (YONSEI BH Arterial Stemcell Clinic) utilizes a unique arterial delivery technology. This targets the brain directly through the blood-brain barrier. Data shows these specialized centers often provide faster access to innovative approaches than the high-volume public hospitals.
Patient Consensus: Patients note that getting biomarker testing early is essential because PET scan schedules fill up quickly in Seoul. Many recommend checking eligibility for clinical trials at university hospitals to access newer medications before they receive full insurance coverage.
Eligible patients must have mild cognitive impairment or mild dementia caused by Alzheimer’s disease. Success requires early-stage diagnosis confirmed by elevated amyloid plaques via PET scans or lumbar punctures. Candidates must maintain specific cognitive scores and have no severe vascular brain disease or anticoagulation needs.
Bookimed Expert Insight: While major centers like Severance Hospital serve over 1.6 million outpatients, early intervention is vital because these drugs slow rather than reverse progression. Our data shows that top Korean clinics often prioritize patients under 65 for specialized research arms. Confirming amyloid status via PET scans at high-volume facilities like Asan Medical Center before symptoms worsen improves inclusion odds.
Patient Consensus: Patients note that testing APOE4 status privately helps avoid eligibility surprises later. Many emphasize that rural residents must travel to Seoul, as primary access to these infusions and specialized MRI monitoring remains concentrated in major capital hospitals.
Wait times for dementia specialists in Korea typically range from 24 to 62 days at major national university hospitals. While local clinics often provide same-week appointments, top-tier centers like Seoul National University Hospital (SNUH) currently report average waits of 57 to 62 days. Patients find faster access in Seoul than rural areas.
Bookimed Expert Insight: While major centers like Asan Medical Center serve over 11,000 outpatients daily, wait times for neurology stay manageable through digital systems. Choosing a clinic with Newsweek-ranked digital infrastructure, such as the BESTcare system at Seoul National University Bundang Hospital, often correlates with more efficient patient flow and scheduling.
Patient Consensus: Patients note that using hospital mobile apps or getting a local referral significantly speeds up the booking process in Seoul. Most report that initial specialist visits usually happen within 10 days despite the heavy volume at major hospitals.
Experimental treatments like arterial stem cell therapy and mesenchymal stem cell research are available in South Korea. Specialized centers use advanced delivery methods to target brain tissue directly. These therapies remain in clinical stages. Patients must verify current trial status through official medical channels.
Bookimed Expert Insight: While many facilities offer standard intravenous injections, the RE:YOUTH clinic in Cheonan differentiates itself by using an arterial delivery method. This technique aims to bypass the lungs and deliver concentrated stem cells directly to the brain via the carotid artery. This specialized approach is rare even in major medical hubs like Seoul.
Patient Consensus: Patients note it is vital to distinguish between commercial clinics and official clinical trials. Many suggest consulting neurologists at large university hospitals to find legitimate research opportunities rather than paying for unproven private treatments.
Government support for dementia includes diagnostic coverage through Medicare Part B and long-term care via Medicaid. Specialized programs provide care navigation, home modifications, and expedited disability benefits. Local agencies offer managed resources like meal delivery and respite grants to support caregivers and patients.
Bookimed Expert Insight: While government programs provide basic care, South Korean centers like Asan Medical Center and Severance Hospital offer advanced digital monitoring. Asan Medical Center manages over 10,000 outpatients daily, indicating a high-volume system that integrates government-supported standards with advanced AI diagnostics. This scale allows for more precise staging than smaller regional clinics.
Patient Consensus: Patients note that navigating federal programs is easier with a dedicated care coordinator. Many emphasize that securing home modification grants early significantly improves daily safety and comfort.
International patients find English support through dedicated international centers at JCI-accredited facilities like Severance Hospital and Asan Medical Center. These centers provide bilingual coordinators and medical interpreters. Coordination teams manage clinical appointments, travel logistics, and visa processing to ensure seamless communication for neurology patients.
Bookimed Expert Insight: While major Seoul hospitals handle over 1,000,000 patients annually, choose centers with specific international accreditations like GHA. These facilities often have more robust English-speaking infrastructure for complex neurological cases. Smaller clinics like RE:YOUTH specialize in niche therapies and provide more personalized English coordination than general hospitals.
Patient Consensus: Patients note that while major Seoul hospitals have English signage, a bilingual companion is often essential for detailed Alzheimer's consultations. Use translation apps like Papago or Google Translate to bridge communication gaps during diagnostic evaluations and daily travel.